Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement-Reference-Cited by-同舟云学术

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement

Published:2021-08-03 Issue:21 Volume:127 Page:3957-3966
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bratslavsky Gennady¹,Mendhiratta Neil²^ORCID,Daneshvar Michael¹³,Brugarolas James⁴,Ball Mark W.³^ORCID,Metwalli Adam⁵,Nathanson Katherine L.⁶⁷,Pierorazio Phillip M.⁸,Boris Ronald S.⁹,Singer Eric A.¹⁰,Carlo Maria I.¹¹,Daly Mary B.¹²,Henske Elizabeth P.¹³,Hyatt Colette¹⁴,Middleton Lindsay⁴,Morris Gloria¹,Jeong Anhyo²,Narayan Vivek⁷¹⁵,Rathmell W. Kimryn¹⁶,Vaishampayan Ulka¹⁷^ORCID,Lee Bruce H.¹⁸,Battle Dena¹⁹,Hall Michael J.²⁰,Hafez Khaled²¹,Jewett Michael A. S.²²,Karamboulas Christina²²,Pal Sumanta K.²³^ORCID,Hakimi A. Ari¹¹,Kutikov Alexander²⁰,Iliopoulos Othon²⁴,Linehan W. Marston³,Jonasch Eric²⁵,Srinivasan Ramaprasad³,Shuch Brian²^ORCID

Affiliation:

1. Department of Urology State University of New York (SUNYUpstate Medical University Syracuse New York

2. Department of Urology University of California Los Angeles Los Angeles California

3. Urologic Oncology Branch Center for Cancer Research National Cancer Institute Bethesda Maryland

4. Department of Medicine Division of Hematology‐Oncology University of Texas (UT) Southwestern Medical Center Dallas Texas

5. Department of Surgery Division of Urology Howard University Hospital Washington District of Columbia

6. Division of Human Genetics and Translational Medicine Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

7. Abramson Cancer Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

8. Brady Urological Institute and Department of Urology Johns Hopkins School of Medicine Baltimore Maryland

9. Indiana University School of Medicine Indianapolis Indiana

10. Section of Urologic Oncology Rutgers Cancer Institute of New Jersey New Brunswick New Jersey

11. Memorial Sloan Kettering Cancer Center New York New York

12. Department of Clinical Genetics Fox Chase Cancer Center Philadelphia Pennsylvania

13. Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts

14. Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia Pennsylvania

15. Division of Hematology/Oncology Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

16. Department of Medicine Vanderbilt University Nashville Tennessee

17. Department of Oncology Karmanos Cancer Center/Wayne State University Detroit Michigan

18. Driven To Cure Silver Spring Maryland

19. The Kidney Cancer Research Alliance Leesburg Virginia

20. Department of Surgery, Division of Urology Fox Chase Cancer Center Philadelphia Pennsylvania

21. Department of Urology University of Michigan Ann Arbor Michigan

22. Division of Urology, Department of Surgery Princess Margaret Cancer Center Toronto Ontario Canada

23. Department of Medical Oncology City of Hope Comprehensive Cancer Center Duarte California

24. Massachusetts General Hospital Cancer Center Boston Massachusetts

25. The University of Texas MD Anderson Cancer Center Houston Texas

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33679

Reference33 articles.

1. Cancer statistics, 2019

2. Hereditary Renal Cell Carcinoma Syndromes

3. Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management

4. Pathogenic Germline Variants in 10,389 Adult Cancers

5. Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome;International Journal of Molecular Sciences;2024-08-21

2. ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndrome;European Journal of Human Genetics;2024-07-31

3. Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma;CA: A Cancer Journal for Clinicians;2024-04-03

4. Multiple and hereditary renal tumors: a review for radiologists;Radiología (English Edition);2024-03

5. Family History and Risk of Renal Cell Carcinoma: A National Multiregister Case-Control Study;Journal of Urology;2024-01